Mebhydrolin Market – Rising Allergy Burden Drives Antihistamine Demand
The mebhydrolin market is expanding as allergic conditions, respiratory discomfort, seasonal allergies, and consumer awareness of antihistamine treatment options increase worldwide. The market was valued at USD 1.5 billion in 2024 and is projected to rise from USD 1.6 billion in 2025 to USD 3.5 billion by 2035, growing at a CAGR of 8.1%. Mebhydrolin is an antihistamine used in treatment...
0 Comments 0 Shares 51 Views 0 Reviews